by Alex Kadhim
Published in Blood Advances, researchers from the MIDAS consortium, including Roswell Park Comprehensive Cancer Center, The Ohio State University, Cincinnati Children’s Medical Center, and...
by Alex Kadhim
Researchers at The University of Texas MD Anderson Cancer Center have demonstrated that permissive human leukocyte antigen (HLA)-DPB1 mismatches can reduce relapse after matched unrelated donor...
by ASTCT Talks
In a cobranded episode between Oncology on the Go, hosted by CancerNetwork®, and the American Society for Transplantation and Cellular Therapy (ASTCT)’s program ASTCT Talks,...
by ASTCT Talks
In this episode of ASTCT Talks, host Dr. Corey Cutler, MD, from Dana-Farber Cancer Institute, is joined by Dr. Pooja Khandelwal, MD (Cincinnati Children’s Hospital), Dr. Ben...
by Alex Kadhim
This study uses social media insights to reveal the substantial physical, emotional, and financial burden experienced by patients and caregivers living with chronic GVHD in the United States....
by Alex Kadhim
This multinational MAGIC consortium study shows that early use of systemic corticosteroids for grade I acute GVHD does not improve survival outcomes and may increase risks such as...